论文部分内容阅读
Objective:To study the efficacy of adjuvant tyrosine kinase inhibitor therapy for non-small cell lung cancer and its influence on survival outcome.Methods: 92 patients with NSCLC who were treated in our hospital between March 2010 and March 2012 were coll